Cognitive & Nootropic

P21

Cerebrolysin-derived peptide · P21 peptide

A synthetic peptide derived from Cerebrolysin, researched for neurogenesis and cognitive enhancement.

Overview & Mechanism

A small peptide designed from Cerebrolysin that promotes neurogenesis and synaptic plasticity, improving cognitive outcomes in animal models.

Research Dosage

Dose

0.5–1 mg/day (research)

Route

Subcutaneous injection

Frequency

Once daily

Cycle

2–4 weeks

Reconstitution & Storage

Reconstitution

Reconstitute per vial concentration with bacteriostatic water.

Storage

Lyophilized: −20 °C. Reconstituted: refrigerate 2–8 °C.

Safety & Side Effects

Early-stage research compound with limited human data.

Studies

P21 and neurogenesis

P21 stimulated neurogenesis and improved cognitive function in animal models, suggesting potential for neurodegenerative conditions.

Read study

References

Research Use Only

This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.